Table 3.
Desensitization protocols suggested for influenza, measles, tetanus, MMR, DPT, yellow fever, and Pfizer-BioNTech® from 1990 to 2021.
| Vaccine | Step | Dose (ml) | Dilution | Time (min) |
|---|---|---|---|---|
| Influenza (9) | 1 | 0.05 | Full strength | q30 |
| 2 | 0.1 | Full strength | ||
| 3 | 0.15 | Full strength | ||
| 4 | 0.2 | Full strength | ||
| Influenza (10) | 1 | 0.05 | 1:100 | q15 |
| 2 | 0.05 | 1:10 | ||
| 3 | 0.05 | Full strength | ||
| 4 | 0.10 | Full strength | ||
| 5 | 0.15 | Full strength | ||
| 6 | 0.20 | Full strength | ||
| H1N1 Influenza (11) | 1 | 0.05 | 1:10 | q15 |
| 2 | 0.05 | Full strength | ||
| 3 | 0.10 | Full strength | ||
| 4 | 0.15 | Full strength | ||
| 5 | 0.20 | Full strength | ||
| Influenza (12) | 1 | 0.05 | 1:1,000,000 | q30 |
| 2 | 0.05 | 1:100,000 | ||
| 3 | 0.05 | 1:10,000 | ||
| 4 | 0.05 | 1:1,000 | ||
| 5 | 0.05 | 1:100 | ||
| 6 | 0.05 | 1:10 | ||
| 7 | 0.05 | Full strength | ||
| 8 | 0.05 | Full strength | ||
| Pfizer BioNTech (5) | 1 | 0.03 | Full strength | q30 |
| 2 | 0.07 | Full strength | ||
| 3 | 0.10 | Full strength | ||
| 4 | 0.10 | Full strength | ||
| Measles (10) | 1 | 0.05 | 1:100 | q15 |
| 2 | 0.05 | 1:10 | ||
| 3 | 0.05 | Full strength | ||
| 4 | 0.05 | Full strength | ||
| 5 | 0.05 | Full strength | ||
| 6 | 0.05 | Full strength | ||
| 7 | 0.05 | Full strength | ||
| 8 | 0.05 | Full strength | ||
| 9 | 0.05 | Full strength | ||
| 10 | 0.05 | Full strength | ||
| 11 | 0.05 | Full strength | ||
| 12 | 0.05 | Full strength | ||
| Measles, Mumps, and Rubella (13) | 1 | 0.05 | 1:100 | q20 |
| 2 | 0.5 | 1:10 | ||
| 3 | 0.05 | Full strength | ||
| 4 | 0.10 | Full strength | ||
| 5 | 0.15 | Full strength | ||
| 6 | 0.20 | Full strength | ||
| Tetanus (14) | 1 | 0.02 | 1:1,000 | q20 |
| 2 | 0.02 | 1:100 | ||
| 3 | 0.02 | 1:100 | ||
| 4 | 0.02 | 1:10 | ||
| 5 | 0.10 | 1:10 | ||
| 6 | 0.05 | Full strength | ||
| 7 | 0.10 | Full strength | ||
| 8 | 0.15 | Full strength | ||
| 9 | 0.20 | Full strength | ||
| Toxoid-containing vaccines (tetanus, diphtheria) (15) | 1 | 0.05 | 1:100 | q20 |
| 2 | 0.05 | 1:10 | ||
| 3 | 0.05 | Full strength | ||
| 4 | 0.10 | Full strength | ||
| 5 | 0.20 | Full strength | ||
| 6 | 0.25 | Full strength | ||
| Yellow Fever (16) | 1 | 0.1 | 1:1,000 | q30 |
| 2 | 0.1 | 1:100 | ||
| 3 | 0.1 | 1:10 | ||
| 4 | 0.05 | Full strength | ||
| 5 | 0.1 | Full strength | ||
| 6 | 0.15 | Full strength | ||
| 7 | 0.2 | Full strength | ||
| Suggested universal desensitization protocol (17) | 1 | 0.05 | 1:10 | q15–20 |
| 2 | 0.05 | Full strength | ||
| 3 | 0.10 | Full strength | ||
| 4 | 0.15 | Full strength | ||
| 5 | 0.20 | Full strength |